Browse Category

NASDAQ:ANF News 25 November 2025 - 12 January 2026

Abercrombie & Fitch stock slides 17% after outlook trim puts tariffs back on the tape

Abercrombie & Fitch stock slides 17% after outlook trim puts tariffs back on the tape

Abercrombie & Fitch shares fell 17.3% to $103.26 after the company cut its full-year sales growth forecast and lowered its holiday-quarter outlook. The retailer now expects fiscal 2025 net sales growth of at least 6%, down from a prior 6%–7% range, and factored in $90 million in tariff expenses. Investors are watching the ICR Conference this week for further updates on demand and pricing.
12 January 2026
Why Abercrombie & Fitch stock is sliding today despite a UBS target hike

Why Abercrombie & Fitch stock is sliding today despite a UBS target hike

Abercrombie & Fitch shares dropped 3.7% to $125.09 Friday after a weaker U.S. jobs report and mixed consumer sentiment data. UBS raised its price target on the stock to $160, citing expected 2026 earnings growth. Payrolls rose by 50,000 in December, with job losses in retail. Investors await the Fed’s Jan. 27-28 meeting and Abercrombie’s next results, expected in early March.
9 January 2026
US Stock Market Today, November 25, 2025: Dow Surges as Fed Rate‑Cut Bets Rise While Nvidia Slumps on Google–Meta AI Chip Shock

US Stock Market Today, November 25, 2025: Dow Surges as Fed Rate‑Cut Bets Rise While Nvidia Slumps on Google–Meta AI Chip Shock

All figures in this article are based on early‑afternoon U.S. trading on Tuesday, November 25, 2025. Levels and percentages may change by the closing bell. Key takeaways Wall Street extends its rebound as Dow takes the lead The U.S. stock market is building on Monday’s powerful rebound, but today’s advance has a different flavor. As of early afternoon Eastern time: The advance keeps Wall Street on track for a third straight day of gains, capping a volatile November that has seen a tech‑led selloff, a government shutdown, and now a relief rally fueled by rising expectations of easier policy from the Federal

Stock Market Today

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

7 February 2026
Bank of America shares rose 2.89% Friday to $56.53, tracking a rally in U.S. financial stocks as the Dow closed above 50,000. The bank will redeem its Series DD preferred stock and related depositary shares on March 10 at $1,000 per share. CEO Brian Moynihan donated 100,000 shares on Feb. 4, a regulatory filing showed. Key U.S. jobs and inflation data are due next week after delays.
Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

7 February 2026
Oracle shares jumped 4.65% to $142.82 Friday, ending an eight-day slide but remaining down 22% since Jan. 27. The company has set up a $20 billion at-the-market stock program and completed a $25 billion senior notes sale to fund cloud expansion. Oracle’s liabilities stood at $174.5 billion as of Nov. 30, 2025, before the new financing. Investors remain focused on dilution risks and the pace of capacity growth.
Go toTop